Comparative efficacy and tolerance of fluvoxamine and amitriptyline in the treatment of moderate and severe depression in mental hospital

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 103, Issue 1, 2003, Pages 24-29

  Kostyukova, E G ^a   Granenov, C M ^a   Andreichik, L A ^a   Serditov, O V ^a   Mosolov, S N ^a  

^a NONE

Author keywords

Amitriptyline; Depression; Fluvoxamine; Selective serotonin reuptake inhibitors; Therapy; Tricyclic antidepressants

Indexed keywords

AMITRIPTYLINE; FLUVOXAMINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERANCE; FEMALE; HOSPITALIZATION; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR DEPRESSION; MALE; MENTAL HOSPITAL; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER, MAJOR; DRUG TOLERANCE; FEMALE; FLUVOXAMINE; HOSPITALIZATION; HOSPITALS, PSYCHIATRIC; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS;

EID: 17144447322     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. 7- Anderson I.M. et al. The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. J Psychopharmacol 1994; 8: 238-249.
2. ECDEU Assessment Manual for Psychopharmacology (revised). Ed. W. Guy. DHEW Publ. NO (ADM) 76-338, Rockville, MD: National Institute of Mental Health 1976.
3. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psy-chiat 1960; 23: 56-62.
4. Crimsley S.R., Jann M.W. Paroxetine, sertraline and fluvoxamine: new selective serotonin reuptake inhibitors. Clin Pharmacol 1992; 11: 930-957.
5. Kielhok P. Psyhiatrische Pharmakotherapie in Klinic und Praxis. Bern - Stuttgart 1965.
6. Kupfer D. SSRIs: state of the art in depression and beyond. Int Med New 1999; 99: 2: 1-3.
7. Nemeroff C.B., Ninan P.T., Ballenger J. et al. Double-blind multi-center comparison of fluvoxamine versus sertraline in treatment of depressed outpatients. Depression 1995; 3: 163-169.
8. Wagner W., Zaborny B., Gray T. Fluvoxamine. A review of its safety profile in world-wide studies. Int Clin Psychopharnfacol 1994; 9: 4: 223-227.
9. Wilde M.I., Plosker G.L., Benfield P. Fluvoxamine: An updated review of its pharmacology, and therapeutic use in depressive illness. Drugs 1993; 46: 395.